GEIGER COUNTER LIMITED
GCL | IL
Overview
Corporate Details
- ISIN(s):
- GB00B15FW330 (+1 more)
- LEI:
- 549300O6PWGLLYV1QX57
- Country:
- Jersey
- Address:
- Ordnance House, JE4 8PW St Helier
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Genedrive PLC develops and commercializes easy-to-use, point-of-care pharmacogenetic tests for improved clinical outcomes. Our tests, such as the CYP2C19 ID Kit and MT-RNR1 ID Kit, are designed for rapid, time-critical settings.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-13 14:23 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-11 11:02 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-06-10 17:46 |
Regulatory News Service
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-06 14:45 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-06 09:05 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-06-05 14:08 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-05 12:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 25.5 KB | |
| 2025-06-04 14:06 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-02 17:02 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-06-02 10:20 |
Transaction in Own Shares
Share Buyback
|
English | 10.4 KB | |
| 2025-05-30 18:03 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-05-29 13:42 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-05-28 18:09 |
Investment Company Reports
Holding(s) in Company
|
English | 25.4 KB | |
| 2025-05-28 14:57 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 11.8 KB | |
| 2025-05-27 16:17 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 12.6 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |